Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TWi BiotechnologyROCO:6610 +0.37%34 Gross Margin % is 0.00% as of Dec. 2025. GuruFocus rates ROCO:6610 with a GF Score™ of 34/100. The stock has 2 warning signs investors should review. Among 733 Biotechnology companies, TWi Biotechnology ranks worse than 136425.51% on this metric.
The historical rank and industry rank for TWi Biotechnology's Gross Margin % or its related term are showing as below:
During the past 13 years, the highestGross Margin % of TWi Biotechnology was 98.62%. The lowest was 16.29%. And the median was 24.39%.
ROCO:6610's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 60.91 * Ranked among companies with meaningful Gross Margin % only.
TWi Biotechnology had a gross margin of N/A% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for TWi Biotechnology was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
TWi Biotechnology had a gross margin of N/A% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
TWi Biotechnology Gross Margin % Related Terms
TWi Biotechnology Gross Margin % Historical Data
* Premium members only.
The historical data trend for TWi Biotechnology's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6610 vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, TWi Biotechnology's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TWi Biotechnology Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, TWi Biotechnology's Gross Margin % distribution charts can be found below:
* The bar in red indicates where TWi Biotechnology's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
TWi Biotechnology (ROCO:6610) has a Gross Margin % of 0.00% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on TWi Biotechnology and its competitors. Over the past decade, TWi Biotechnology's Gross Margin % has ranged from 16.29 to 98.62. According to the industry distribution chart, TWi Biotechnology ranks #999999 out of 733 companies in the Biotechnology industry.
Is TWi Biotechnology's Gross Margin % too high?
TWi Biotechnology's current Gross Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 16.29 to a high of 98.62. Based on the distribution chart, TWi Biotechnology ranks #999999 out of 733 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, TWi Biotechnology has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does TWi Biotechnology's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, TWi Biotechnology ranks #999999 out of 733 companies for Gross Margin %. This places TWi Biotechnology in the lower half of its industry. The industry median Gross Margin % is 60.91. Historically, TWi Biotechnology's own Gross Margin % has ranged from 16.29 to 98.62 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 733 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on TWi Biotechnology and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TWi Biotechnology's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TWi Biotechnology stock overvalued right now?
TWi Biotechnology (ROCO:6610) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. TWi Biotechnology's overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For TWi Biotechnology (ROCO:6610), the current Gross Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TWi Biotechnology Inc is a clinical-stage biopharmaceutical company based in Taiwan. It is engaged in the development of new drugs for unmet medical needs, particularly in the diseases associated with innate immunity. The pipeline products of the company comprise AC-201, AC-203, and AC-701.
34GF Score
Get the complete analysis for ROCO:6610
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6610 has been successfully added to your 
